These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31257696)

  • 1. Low hemoglobin A1c and low body mass index are associated with dementia and activities of daily living disability among Japanese nursing home residents with diabetes.
    Hatano Y; Araki A; Matsumoto M; Ishibashi S
    Geriatr Gerontol Int; 2019 Sep; 19(9):854-860. PubMed ID: 31257696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia.
    Thorpe CT; Gellad WF; Good CB; Zhang S; Zhao X; Mor M; Fine MJ
    Diabetes Care; 2015 Apr; 38(4):588-95. PubMed ID: 25592195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.
    Abbatecola AM; Bo M; Armellini F; D'Amico F; Desideri G; Falaschi P; Greco A; Guerrini G; Lattanzio F; Volpe C; Paolisso G
    Metabolism; 2015 Nov; 64(11):1500-6. PubMed ID: 26318195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus.
    Lapane KL; Jesdale BM; Dubé CE; Pimentel CB; Rajpathak SN
    Diabetes Res Clin Pract; 2015 Aug; 109(2):411-9. PubMed ID: 26008723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
    Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
    JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A
    BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
    Lipska KJ; Ross JS; Miao Y; Shah ND; Lee SJ; Steinman MA
    JAMA Intern Med; 2015 Mar; 175(3):356-62. PubMed ID: 25581565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
    Umpierrez GE; Cardona S; Chachkhiani D; Fayfman M; Saiyed S; Wang H; Vellanki P; Haw JS; Olson DE; Pasquel FJ; Johnson TM
    J Am Med Dir Assoc; 2018 May; 19(5):399-404.e3. PubMed ID: 29289540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative safety of dipeptidyl peptidase-4 inhibitors and sulfonylureas among frail older adults.
    Zullo AR; Smith RJ; Gutman R; Kohler B; Duprey MS; Berry SD; Munshi MN; Dore DD
    J Am Geriatr Soc; 2021 Oct; 69(10):2923-2930. PubMed ID: 34291453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study.
    Fu H; Curtis BH; Schuster DP; Festa A; Kendall DM
    Diabetes Technol Ther; 2014 Dec; 16(12):833-9. PubMed ID: 25068375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03).
    Yamamoto-Honda R; Takahashi Y; Mori Y; Yamashita S; Yoshida Y; Kawazu S; Iwamoto Y; Kajio H; Yanai H; Mishima S; Handa N; Shimokawa K; Yoshida A; Watanabe H; Ohe K; Shimbo T; Noda M
    Intern Med; 2018 May; 57(9):1229-1240. PubMed ID: 29279487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015.
    Misra-Hebert AD; Pantalone KM; Ji X; Milinovich A; Dey T; Chagin KM; Bauman JM; Kattan MW; Zimmerman RS
    Diabetes Care; 2018 Jun; 41(6):1164-1171. PubMed ID: 29549082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
    Lajara R; Aguilar R; Hehnke U; Woerle HJ; von Eynatten M
    Clin Ther; 2014 Nov; 36(11):1595-605. PubMed ID: 25236917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas - a meta-analysis from randomized clinical trials.
    Zhang Y; Hong J; Chi J; Gu W; Ning G; Wang W
    Diabetes Metab Res Rev; 2014 Mar; 30(3):241-56. PubMed ID: 24123720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents.
    Chan SP; Colagiuri S
    Diabetes Res Clin Pract; 2015 Oct; 110(1):75-81. PubMed ID: 26361859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy and safety of linagliptin in elderly patients with type 2 diabetes: a pooled analysis of eight placebo-controlled clinical trials].
    Guo XH; Feng ZK; Xu LH
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):588-594. PubMed ID: 28789492
    [No Abstract]   [Full Text] [Related]  

  • 19. A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.
    Ampudia-Blasco FJ; Benhamou PY; Charpentier G; Consoli A; Diamant M; Gallwitz B; Khunti K; Mathieu C; Ridderstråle M; Seufert J; Tack C; Vilsbøll T; Phan TM; Stoevelaar H
    Diabetes Technol Ther; 2015 Mar; 17(3):194-202. PubMed ID: 25347226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus.
    Katsuno T; Ikeda H; Ida K; Miyagawa J; Namba M
    Endocr J; 2013; 60(6):733-42. PubMed ID: 23386390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.